abs139.txt	context		radioactive	iodine	(rai)	has	been	epidemiologically	associated	with	thedevelopment	of	hematologic	malignancies		clonal	hematopoiesis	(ch)	is	a	precursorclonal	state	that	confers	increased	risk	of	leukemia	and	occurs	at	an	elevatedrate	in	patients	with	thyroid	cancer	relative	to	other	solid	tumors	objective		we	explore	if	the	high	prevalence	of	ch	may	be	a	result	of	raiexposure	and	whether	ch	may	be	a	surrogate	in	the	association	between	rai	andleukemia	design		ch		ch-potential	driver	(ch-pd)		and	overall	survival	were	evaluated	in279	patients	with	advanced	thyroid	carcinoma	results		the	prevalence	of	ch	in	patients	with	thyroid	cancer	was	37%		and	thatof	ch-pd	was	5	2%		age	was	the	strongest	predictor	of	ch	and	ch-pd		for	everyyear	increase	in	age		there	was	a	5%	and	13%	increase	in	the	odds	of	ch	andch-pd		respectively		rai	dose	was	significantly	associated	with	ch	and	ch-pd	even	after	adjustment	for	age		external	beam	radiation	therapy		and	chemotherapy	for	every	10	mci	increase	in	the	dose	of	rai	administered		there	was	a	2%	and	4%increase	in	the	odds	of	ch	and	ch-pd		respectively		patients	with	ch-pdpreviously	exposed	to	rai	had	a	significantly	poorer	survival		even	whenstratified	by	age	(heart	rate	=	3	75		95%	ci	=	1	23	to	11	5		p	=	0	02)	conclusions		rai	was	associated	with	a	high	prevalence	of	ch		and	ch	is	aprecursor	state	of	hematologic	malignancies		the	implications	of	this	study	mayfavor	identification	of	ch	in	patients	where	the	risks	might	outweigh	thebenefits	of	receiving	rai	therapy	for	thyroid	cancer	
